Brind.

LabCorp is gaining Medicare coverage for its cancer testing offerings, which utilize companion diagnostics from Hoffmann-La Roche.

2 reports, 2 independent Updated Aug 14

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

LabCorp is gaining Medicare coverage for its cancer testing offerings, which utilize companion diagnostics from Hoffmann-La Roche.

Who's involved

What this event is mainly about

LabCorp Hoffmann-La Roche Medicare

Keep exploring

The entities involved

LabCorp
clinical laboratory company
- LabCorp acquired the outreach laboratory services of Community Health Systems.Sun 11:52
- The state of Alaska reached a settlement with LabCorp regarding a breach while managing oil revenues for the dividend.Sat 02:32
Hoffmann-La Roche
Swiss healthcare company
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
- Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
Medicare
US federal health insurance
- Advocates are calling for guardrails on AI development following a recent hack of the Medicare system.Mon 15:20
- Leaders call for slowing AI development pace, concurrent with an AI model built by OpenAI being hacked via the Medicare portal.Mon 15:20

Related events

The FDA has delayed potential approval of a cancer treatment that utilizes Exelixis in combination with Roche's Tecentriq.Sep 11

Coverage

Newest first; wire copies grouped

Aug 14finanznachrichten.de
Aug 1themarketsdaily.com